Fatty acid synthase (FASN), a key enzyme of de novo lipid synthesis, is the most targetable among lipogenesis genes due to its high degree of overexpression in cancer cells as compared to normal epithelial cells [3,4,5]. The gene discussed is FASN; the disease is cancer.